Table 7. Blood glucose and complications of the diabetes population in this study, median (IQR) or n (%).
| Variables | Total (n = 1507) | Rural (n = 513) | Urban (n = 994) | p-value |
|---|---|---|---|---|
| FBS (mmol/l) | 8.51 (6.94–10.90) | 8.55 (6.92–11.20) | 8.45 (6.96–10.78) | 0.554 |
| FBS (> 7mmol/l) | 1106 (73.6) | 376 (73.3) | 730 (73.7) | 0.853 |
| HbA1c (%) | 8.00 (6.80–9.30) | 7.90 (6.83–9.30) | 8.00 (6.80–9.30) | 0.900 |
| HbA1c (> 7%) | 968 (69.6) | 356 (71.5) | 612 (68.6) | 0.263 |
| HbA1c (> 8%) | 789 (52.4) | 247 (48.1) | 542 (54.5) | 0.019 |
| HbA1c (> 9%) | 406 (26.9) | 141 (27.5) | 265 (26.7) | 0.732 |
| Diabetes Medications | ||||
| None | 495 (35.5) | 203 (40.8) | 292 (32.6) | |
| 1 | 353 (25.3) | 122 (24.5) | 231 (25.8) | |
| 2 | 366 (26.2) | 120 (24.1) | 246 (27.4) | |
| ≥ 3 | 181 (13.0) | 53 (10.6) | 128 (14.3) | 0.012 |
| Biguanide | 617 (44.0) | 192 (38.6) | 425 (47.0) | 0.002 |
| Sulfonylurea | 88 (6.3) | 24 (4.8) | 64 (7.1) | 0.088 |
| Thiazolidenedione | 10 (0.7) | 1 (0.2) | 9 (1.0) | 0.089 |
| Alpha glucosidase inhibitor | 148 (10.6) | 48 (9.6) | 100 (11.1) | 0.384 |
| DPP4 inhibitor | 41 (2.9) | 6 (1.2) | 35 (3.9) | 0.004 |
| Insulin | 630 (44.6) | 220 (43.8) | 410 (45.1) | 0.643 |
| Exenatide or Liraglutide | 7 (0.5) | 1 (0.2) | 6 (0.7) | 0.236 |
| Glinides | 134 (9.6) | 36 (7.2) | 98 (10.9) | 0.024 |
| Diabetes-related complications n (%) | ||||
| None | 363 (26.0) | 138 (27.8) | 225 (25.1) | |
| Yes | 1031 (74.0) | 359 (72.2) | 672 (74.9) | |
| 1 | 404 (29.1) | 148 (29.8) | 256 (28.5) | |
| 2 | 285 (20.4) | 104 (20.9) | 181 (20.2) | |
| ≥3 | 342 (24.5) | 107 (21.5) | 235 (26.2) | 0.263 |
| Macrovascular complications | ||||
| CAD | 469 (33.4) | 156 (31.3) | 313 (34.5) | 0.221 |
| Stroke/TIA | 156 (11.2) | 63 (12.7) | 93 (10.4) | 0.192 |
| Large artery atherosclerosis | 539 (38.6) | 174 (34.9) | 365 (40.7) | 0.035 |
| Microvascular complications | ||||
| Retinopathy | 353 (25.2) | 109 (21.9) | 244 (27.1) | 0.032 |
| Nephropathy | 98 (7.0) | 31 (6.2) | 67 (7.5) | 0.384 |
| Neuropathy | 540 (38.7) | 173 (34.7) | 367 (40.8) | 0.025 |
| DFD | 21 (1.5) | 11 (2.2) | 10 (1.1) | 0.108 |
Data is presented as median (IQR) or n (%); Chi-square or Fisher’s test. p < 0.05 was considered significant difference. n: number, DFD: Diabetic Foot Disease.